5-132595759-TAA-TA
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_005732.4(RAD50):c.2165delA(p.Lys722ArgfsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000748 in 1,444,452 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005732.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndrome-like disorderInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | c.2165delA | p.Lys722ArgfsTer14 | frameshift_variant | Exon 13 of 25 | ENST00000378823.8 | NP_005723.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RAD50 | ENST00000378823.8 | c.2165delA | p.Lys722ArgfsTer14 | frameshift_variant | Exon 13 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
| ENSG00000283782 | ENST00000638452.2 | c.1868delA | p.Lys623ArgfsTer14 | frameshift_variant | Exon 15 of 27 | 5 | ENSP00000492349.2 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150312Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000142 AC: 34AN: 239710 AF XY: 0.000177 show subpopulations
GnomAD4 exome AF: 0.0000748 AC: 108AN: 1444452Hom.: 0 Cov.: 31 AF XY: 0.0000709 AC XY: 51AN XY: 718916 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000266 AC: 4AN: 150312Hom.: 0 Cov.: 32 AF XY: 0.0000273 AC XY: 2AN XY: 73298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.2165delA variant, located in coding exon 13 of the RAD50 gene, results from a deletion of one nucleotide at nucleotide position 2165, causing a translational frameshift with a predicted alternate stop codon (p.K722Rfs*14). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
This sequence change creates a premature translational stop signal (p.Lys722Argfs*14) in the RAD50 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAD50 are known to be pathogenic (PMID: 19409520). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 32868316, 35220195). This variant is also known as c.2157delA, c.2157del. ClinVar contains an entry for this variant (Variation ID: 408407). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at